Effect of Anti-parkinsonian Medications on Gait and Balance in Individuals with Parkinson's Disease

被引：0
|
作者：
Protas, Elizabeth J. [1 ]
Bryant, Monthaporn [2 ]
Fernandez, Angel [1 ]
机构：
[1] Univ Texas Med Branch, Galveston, TX USA
[2] Baylor Coll Med, Houston, TX 77030 USA
来源：
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE | 2008年 / 40卷 / 05期
关键词：
D O I：
10.1249/01.mss.0000322847.36434.09
中图分类号：
G8 [体育];
学科分类号：
04 ; 0403 ;
摘要：
引用
收藏
页码：S434 / S434
页数：1
相关论文
共 50 条
  • [1] Evolution of anti-parkinsonian drug prescribing patterns in Parkinson's disease
    Neo, S.
    Wong, A.
    Ng, H. L.
    Li, W.
    Tay, K. Y.
    Au, W. L.
    Tan, L.
    [J]. MOVEMENT DISORDERS, 2019, 34 : S143 - S143
  • [2] Anti-Parkinsonian Activity of Ganoderma Lucidum in Experimentally Induced Parkinson's Disease
    Aslam, Sana
    Aslam, Muhammad
    Kauser, Hania
    Naqvi, Sara
    [J]. JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (52B) : 266 - 275
  • [3] Dopamine Transporter Imaging in Parkinson Disease: Progressive Changes and Therapeutic Modification after Anti-parkinsonian Medications
    Ikeda, Ken
    Ebina, Junya
    Kawabe, Kiyokazu
    Iwasaki, Yasuo
    [J]. INTERNAL MEDICINE, 2019, 58 (12) : 1665 - 1672
  • [4] Classical Neurotransmitters and Neuropeptides Involved in Parkinson's Disease: Focus on Anti-Parkinsonian Drugs
    Werner, Felix-Martin
    Covenas, Rafael
    [J]. CURRENT DRUG THERAPY, 2015, 10 (02) : 66 - 81
  • [5] Modeling of the early clinical stage of Parkinson's disease for testing of anti-parkinsonian drugs
    Kolacheva, A.
    Kozina, E.
    Khakimova, G.
    Ugrumov, M.
    [J]. FEBS JOURNAL, 2013, 280 : 435 - 435
  • [6] Neuroinflammation following anti-parkinsonian drugs in early Parkinson’s disease: a longitudinal PET study
    Tatsuhiro Terada
    Tomoyasu Bunai
    Takanori Hashizume
    Takashi Matsudaira
    Masamichi Yokokura
    Hirotsugu Takashima
    Takashi Konishi
    Tomokazu Obi
    Yasuomi Ouchi
    [J]. Scientific Reports, 14
  • [7] Assessment of Sensorized Insoles in Balance and Gait in Individuals With Parkinson's Disease
    Pergolini, Andrea
    Bowman, Thomas
    Lencioni, Tiziana
    Marzegan, Alberto
    Meloni, Mario
    Carrozza, Maria Chiara
    Trigili, Emilio
    Vitiello, Nicola
    Cattaneo, Davide
    Crea, Simona
    [J]. IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING, 2024, 32 : 1445 - 1454
  • [8] Neuroinflammation following anti-parkinsonian drugs in early Parkinson's disease: a longitudinal PET study
    Terada, Tatsuhiro
    Bunai, Tomoyasu
    Hashizume, Takanori
    Matsudaira, Takashi
    Yokokura, Masamichi
    Takashima, Hirotsugu
    Konishi, Takashi
    Obi, Tomokazu
    Ouchi, Yasuomi
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01)
  • [9] The influence of the renal excretion of anti-parkinsonian drugs in patients with Parkinson's disease associated with chronic kidney disease
    Ryo, M.
    Akiyama, K.
    Mochizuki, H.
    Yoshii, F.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 374 - 374
  • [10] Anti-parkinsonian medication may aggravate constipation in patients with newly diagnosed idiopathic Parkinson's disease
    Son, T. O.
    Youn, J.
    Cho, J. W.
    [J]. MOVEMENT DISORDERS, 2014, 29 : S569 - S569
12345